ARCHIVES

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

This article is from The Cancer Letter archive.

Vol. 13 No. 16 | April 17, 1987

Download PDF Visit The Full Archive

Related Articles

Meharry, Vanderbilt Win Grant For Research Collaboration.

March 30, 2001

NCI Offers Coded Serum Panels

May 28, 1982

Feds Should Lead Quality Improvement In Government Health Programs, IOM Report Says

November 8, 2002

Cancer Patients Satisfied With Experience In Clinical Trials, Survey Of 2,000 Finds

July 28, 2006

Tracor Lands Second Biggest NCI Contract-$6.6 Million To Manage Commercial Labs’ Portion Of Bioassay Program

April 19, 1974

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002